Patch: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial
By K. de Gans, R. J. de Haan, C. Majoie, Maria M Koopman, A. Brand, M. Dijkgraaf, M. Vermeulen, Yvo B. W. E. M. Roos. BMC Neurology, 2010
4,716 citations recorded by the source corpus.
BackgroundPatients suffering from intracerebral haemorrhage have a poor prognosis, especially if they are using antiplatelet therapy. Currently, no effective acute treatment option for intracerebral haemorrhage exists. Limiting the early growth of intracerebral haemorrhage volume which continues the first hours after admission seems a promising strategy. Because intracerebral haemorrhage patients who are on antiplatelet therapy have been shown to be particularly at risk of early haematoma growth, platelet transfusion may have a beneficial effect.Methods/DesignThe primary objective is to investigate whether platelet transfusion improves outcome in intracerebral haemorrhage patients who are on antiplatelet treatment. The PATCH study is a prospective, randomised, multi-centre study with open treatment and blind endpoint evaluation. Patients will be randomised to receive platelet transfusion within six hours or standard care. The primary endpoint is functional health after three months. The main secondary endpoints are safety of platelet transfusion and the occurrence of haematoma growth. To detect an absolute poor outcome reduction of 20%, a total of 190 patients will be included.DiscussionTo our knowledge this is the first randomised controlled trial of platelet transfusion for an acute haemorrhagic disease.Trial registrationThe Netherlands National Trial Register (NTR1303)
Subfields: Biochemistry, Epidemiology, Neurology
View Paper: https://www.semanticscholar.org/paper/9f933dce40546eb06deb9b03581d3749b3ebb827
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Neurology
Citations in the corpus
- The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition (2016, background): “The 10 results of a multi-centre RCT on platelet transfusion in patients with APA-associated ICH are 11 awaited [548].”
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations (2018, background): “Increased Th1- and CTLA-4-associated gene expression (77).”
- Transforming Experience: The Potential of Augmented Reality and Virtual Reality for Enhancing Personal and Clinical Change (2016, background): “However, its potential in supporting personal change is wider as demonstrated by different emerging applications: from poststroke (34) and physical rehabilitation (35, 36), social (37) and emotional (38) training for children with autism, to pain reduction (39).”